A Defining Moment in the Next 36 Hours

36 Hours to Potentially Change Your Future Friday, June 28th, 2013   Dear Daily Reckoning Reader, Your time is precious. So we'll get right to the point... This could be your last chance to view the most controversial (and lucrative) opportunity we've ever discovered. It details a little-known biotech firm whose research is causing religious and political turmoil all over the world. But the implications for life as we know it are simply mind-blowing. Shares of this company are likely to skyrocket very soon. So we wanted to make sure you had the chance to learn how to get in before the jump. That's why we're pulling this video offline tomorrow. That's why you need to act now. Watch this urgent presentation now, because in just 36 hours, you'll no longer have the option. Regards, Greg Kadajski Managing Editor, The Daily Reckoning     The Daily Reckoning is committed to protecting and respecting your privacy. We do not rent or share your email address. To end your Daily Reckoning e-mail subscription and associated external offers sent from Daily Reckoning, feel free to click here to unsubscribe. Please read our Privacy Statement. For any further comments or concerns please email us at dr@dailyreckoning.com. If you are you having trouble receiving your Daily Reckoning subscription, you can ensure its arrival in your mailbox by whitelisting the Daily Reckoning. © 2013 Agora Financial, LLC. 808 Saint Paul Street, Baltimore MD 21202. A lthough our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security they personally recommend to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation.Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.